
Doctors Without Borders calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug
As Johnson & Johnson’s (J&J) 20-year primary patent on the critical, lifesaving drug-resistant tuberculosis (DR-TB) drug bedaquiline expires in majori...








